GlassScriptPhysician profile
Syed Naqvi
NPI 1255631099
$15,312.47
in general payments reported to CMS, 2019-2025
30 companies · $9,345 in 2025
The $9,345 reported for 2025 was more than what 92% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2021: $132 · 2022: $702 · 2023: $2,005 · 2024: $2,705 · 2025: $9,345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,117 · Food and Beverage: $5,406 · Travel and Lodging: $1,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,116.71 |
| Food and Beverage | $5,405.93 |
| Travel and Lodging | $1,532.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,966.67 | 2019-2025 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $1,178.77 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,109.17 | 2022-2025 | Tezspire, Fasenra, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $855.32 | 2022-2025 | Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $519.39 | 2023-2025 | Dupixent |
| Genzyme Corporation | $518.75 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $252.37 | 2019-2025 | |
| Grifols USA, LLC | $245.67 | 2023-2025 | Prolastin-C Liquid |
| Amgen INC. | $181.32 | 2023-2025 | Tezspire |
| Merck Sharp & Dohme LLC | $166.30 | 2019-2024 | Winrevair |
| Siemens Medical Solutions USA, INC. | $138.49 | 2024 | |
| Insmed, INC. | $135.51 | 2025 | Arikayce, Brinsupri |
| Baxter Healthcare | $133.54 | 2023-2024 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Actelion Pharmaceuticals US, INC. | $133.45 | 2021-2024 | Opsumit, Uptravi |
| Sanofi-Aventis U.S. LLC | $127.76 | 2024-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $121.95 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $112.79 | 2022 | |
| La Jolla Pharmaceutical Company | $94.20 | 2021 | |
| Inogen, INC. | $67.74 | 2022-2024 | |
| Electromed, INC. | $34.95 | 2025 | Smartvest |
| Abbvie INC. | $31.39 | 2023 | |
| United Therapeutics Corporation | $31.08 | 2023-2025 | Tyvaso, Tyvaso |
| Genentech USA, INC. | $27.97 | 2023 | Xolair |
| Janssen Biotech, INC. | $25.92 | 2023 | |
| Gilead Sciences, INC. | $24.21 | 2022-2023 | Veklury |
| Vifor Pharma, INC. | $19.26 | 2024 | Zemaira |
| Alexion Pharmaceuticals, INC. | $17.12 | 2024 | Ultomiris |
| Inspire Medical Systems, INC. | $15.77 | 2025 | Inspire |
| Mylan Specialty L.P. | $12.86 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Naqvi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.